| 摘要 |
#CMT# #/CMT# Coloring composition comprises amino pyrazolopyridine oxidation bases (I) or (II), and one or more dye comprising indole compound (III) or benzene-1,2,4-triol, in a coloring medium. #CMT# : #/CMT# Coloring composition comprises amino pyrazolopyridine oxidation bases of formulae (I) or (II), and one or more dye comprising indole compound of formula (III) or benzene-1,2,4-triol, in a coloring medium. R1-R5H, halo, -NHSO3H, OH, (1-4C)alkyl, (1-4C)alkoxy, (1-4C)alkylthio, mono(1-4C)alkylamino, di(1-4C)alkylamino (where the two alkyl groups can join with N atom of which they are bound, to form a cycle (interrupted by N, O or S)), heterocycle, NO2, phenyl, carbonyl, alkoxy(1-4C)carbonyl, carboxamido, CN, amino, sulfonyl, -CO2H, -SO3H, - PO3H2, -PO4H2 or hydrocarbon compound of formula (-Q-C(=R1c)-Y1); R1cO or N; Q : O, NH or NH(1-4c)alkyl; Y1OH, amino, 1-4C alkyl, (1-4C)alkoxy, (1-4C)alkylamino or di(1-4C)alkylamino; Z1, Z2simple covalent bond or divalent radical comprising -O(CH2)p- or -NR6a(CH2)q(C6H4)t-; R6aH or 1-6C alkyl (optionally substituted by OH); R1a, R2aH, 1-10Calkyl (optionally substituted and interrupted by heteroatom, O, N, Si, S, SO or SO2), halo, SO3H, cycle comprising 5-8 chains, where the cycle is cationic and/or substituted by cationic radical (optionally substituted, saturated, or aromatic, and containing heteroatom, N, O, S, SO2 or -CO), -N+>R17R18R19, 1-6C alkylcarbonyl (optionally substituted), -O-CO-R, -CO-O-R, NR-CO-R1d or -CO-NRR1d; R17-R191-5C alkyl (optionally substituted by OH); either R3a, R4a, R5aH, OH, 1-6C alkoxy, 1-6C alkylthio, amino, monoalkylamino, 1-6C dialkylamino(where the alkyl radical can form with N atom to which they are attached a heterocycle comprising 5-8 chains, optionally saturated, aromatic, being able to contain heteroatom or group comprising N, O, S, SO2, CO, and the heterocycle which can be cationic, and/or substituted by cationic radical), 1-6C alkylcarbonyl (optionally substituted), -O-CO-R, -CO-O-R, NR-CO-R1d or - CO-NRR1d, halo, -NHSO3H, 1-4C alkyl (optionally substituted), or carbonated cycle (optionally saturated, aromatic and substituted); or R3aR4aR5aform two to two cycle (optionally saturated); R, R1dH or 1-6C alkyl (optionally substituted); X : ion or group of ions allowing to ensures the electronegativity of (II); R11H, 1-10C (preferably 1-6C)alkyl, 1-10C (poly)hydroxyalkyl, preferably 1-6C; R12H, carboxyl, 1-10C (preferably 1-6C)alkyl or 1-10C (preferably 1-6C)alkoxycarbonyl; R13H, 1-10C (preferably 1-6C)alkyl; R14, R15H, 1-10C (preferably 1-6C)alkyl or 1-10C (preferably 1-6C)alkoxycarbonyl; p, q : 0-6; and t : 0-1. Provided that: (A) the Z1 is divalent radical comprising -S, -SO-, -SO2, when R1a is CH3; (B) when Z1, Z2 represents a covalent bond, then R1a, R2a represents a divalent radical; and (C) at least one of the R1a and R2a is a cationic radical. Independent claims are included for: (1) a process of oxidation coloring of keratin fibers, comprising applying the composition on fibers, in the presence of an oxidizing agent or oxygen to develop desired color; and (2) a device with several compartments comprising a first compartment containing the coloring composition and a second compartment containing oxidizing agent. #CMT#[Image]#/CMT# #CMT#USE : #/CMT# The composition is useful for coloring keratin fibers (claimed), preferably human hair. #CMT#ADVANTAGE : #/CMT# The composition: is non-toxic; and provides desired shades and good stability against external agents such as light, harsh weather, washing, perming, transpiration and rubbing. #CMT#ORGANIC CHEMISTRY : #/CMT# Preferred Composition: The composition further comprises one or more additional oxidation bases and couplers. Preferred Components: (I) is pyrazolo[1,5-a]pyridin-3-ylamine, 2-acetylamino pyrazolo-[1,5-a] pyridin-3-ylamine, 2-morpholin-4-yl-pyrazolo[1,5-a]pyridin-3-ylamine, 3-amino-pyrazolo[1,5-a]pyridin-2-carboxylic acid, 2-methoxy-pyrazolo[1,5-a]pyridine-3-ylamino, (3-amino-pyrazolo[1,5-a]pyridine-7-yl)-methanol, 2-(3-amino-pyrazolo[1,5-a]pyridine-5-yl)-ethanol, 2-(3-amino-pyrazolo[1,5-a]pyridine-7-yl)-ethanol, (3-amino-pyrazolo[1,5-a]pyridine-2-yl)-methanol, 3,6-diamino-pyrazolo[1,5-a]pyridine, 3,4-diamino-pyrazolo[1,5-a]pyridine, pyrazolo[1,5-a]pyridine-3,7-diamine, 7-morpholin-4-yl-pyrazolo[1,5-a]pyridin-3-ylamine, pyrazolo[1,5-a]pyridine-3,5-diamine, 5-morpholin-4-yl-pyrazolo[1,5-a]pyridin-3-ylamine, 2-[(3-amino-pyrazolo[1,5-a]pyridin-5-yl)-(2-hydroxyethyl)-amino]-ethanol, 2-[(3-amino-pyrazolo[1,5-a]pyridin-7-yl)-(2-hydroxyethyl)-amino]-ethanol, 3-amino-pyrazolo[1,5-a]pyridine-5-ol, 3-amino-pyrazolo[1,5-a]pyridine-4-ol, 3-amino-pyrazolo[1,5-a]pyridine-6-ol, 3-amino-pyrazolo[1,5-a]pyridine-7-ol, -2-methoxy-6,7-dimethylpyrazolo[1,5-a]pyridin-3-amine, 2-[(3-aminopyrazolo[1,5-a]pyridin-2-yl)oxy]ethanol, 4-ethyl-2-methoxy-7-methylpyrazolo[1,5-a]pyridin-3-amine hydrochloride, 1-(3-aminopyrazolo[1,5-a]pyridin-2-yl)pyrrolidin-3-ol, 2,2'-[(3-aminopyrazolo[1,5-a]pyridin-2-yl)imino]diethanol, 2-[(3-aminopyrazolo[1,5-a]pyridin-2-yl)amino]ethanol and N2-(2-pyridin-3-ylethyl)pyrazolo[1,5-a]pyridine-2,3-diamine. (II) is salts of: 3-(3-amino-pyrazolo[1,5-a]pyridin-2-yl)-1-methyl-3H-imidazol-1-ium; [2-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-ethyl]-ethyl-dimethyl-ammonium; [2-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-ethyl]-(2-hydroxy-ethyl)-dimethyl-ammonium; [3-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-propyl]-trimethyl-ammonium; [4-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-butyl]-trimethyl-ammonium; [5-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-pentyl]-trimethyl-ammonium; 3-[2-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-ethyl]-1-methyl-3H-imidazol-1-ium; 3-[3-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-propyl]-1-methyl-3H-imidazol-1-ium; 3-[3-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-propyl]-1-(2-hydroxy-ethyl)-3H-imidazol-1-ium; 3-[2-(3-amino-pyrazolo[1,5-a]pyridin-2-yloxy)-ethyl]-1-(2-hydroxy-ethyl)-3H-imidazol-1-ium; 1-{2-[(3-aminopyrazolo[1,5-a]pyridin-2-yl)oxy]ethyl}-1-methylpyrrolidinium; 1-{2-[(3-aminopyrazolo[1,5-a]pyridin-2-yl)oxy]ethyl}-1-methylpiperidinium; 4-{2-[(3-aminopyrazolo[1,5-aipyridin-2-yl)oxy1ethyl}-4-methylmorpholin-4-ium; {2-[(3-aminopyrazolo[1,5-a]pyridin-2-yl)oxy]ethyl}-trimethyl-ammonium; {2-[(3-aminopyrazolo[1,5-a]pyridin-2-yl)oxy]ethyl}-diisopropyl-methyl-ammonium; 1-(3-aminopyrazolo[1,5-a]pyridin-2-yl)-1-methylpyrrolidinium; [1-(3-amino-pyrazolo[1,5-a]pyridin-2-yl)-pyrrolidin-3-yl]-trimethyl-ammonium; 1-[3-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-propyl]-1-methylpiperidinium; 4-(3-amino-pyrazolo[1,5-a]pyridin-2-yl)-1,1-dimethyl-piperazin-1-ium; 4-[2-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-ethyl]-1,1-dimethyl-piperazin-1-ium; 4-[2-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-ethyl]-1-methyl-1-propyl-piperazin-1-ium; 4-(3-amino-pyrazolo[1,5-a]pyridin-2-yl)-1-(2-hydroxy-ethyl)-piperazin-1-ium; [4-(3-amino-pyrazolo[1,5-a]pyridin-2-ylamino)-phenyl]-trimethyl-ammonium; 3-[3-(3-amino-pyrazolo[1,5-a]pyridin-2-yloxy)-propyl]-1-methyl-3H-imidazol-1-ium; 4-(3-amino-pyrazolo[1,5-a]pyridin-2-yl)-1,1-dimethyl-[1,4]diazepan-1-ium; [2-(3-amino-6,7-dimethyl-pyrazolo[1,5-a]pyridin-2-ylamino)-ethyl]-trimethyl-ammonium; 4-(3-amino-6,7-dimethyl-pyrazolo[1,5-a]pyridin-2-yl)-1,1-dimethyl-piperazin-1-ium; 4-(3-amino-6,7-dimethyl-pyrazolo[1,5-a]pyridin-2-yl)-1-(2-hydroxy-ethyl)-1-methyl-piperazin-1-ium; [1-(3-amino-6,7-dimethyl-pyrazolo[1,5-a]pyridin-2-yl)-pyrrolidin-3-yl]-trimethyl-ammonium; 1-(3-amino-6,7-dimethylpyrazolo[1,5-a]pyridin-2-yl)-1 -methylpyrrolidinium; [1-(3-amino-6,7-dimethyl-pyrazolo[1,5-a]pyridin-2-yl)-pyrrolidin-3-yl]-(2-hydroxy-ethyl)-dimethyl-ammonium; {1-[2-(3-amino-6,7-dimethyl-pyrazolo[1,5-a]pyridin-2-yloxy)-ethyl]-pyrrolidin-3-yl}-trimethyl-ammonium; 1-{2-[(3-amino-6,7-dimethylpyrazolo[1,5-a]pyridin-2-yl)oxy]ethyl}-1-methyl pyrrolidinium; 1-{2-[(3-amino-6,7-dimethylpyrazolo[1,5-aipyridin-2-yl)oxy1ethyl}-1-methylpiperidinium; 4-{2-[(3-amino-6,7-dimethylpyrazolo[1 ,5-a]pyridin-2-yl)oxy]ethyl}-4-methylmorpholin-4-ium; {2-[(3-amino-6,7-dimethylpyrazolo[1,5-a]pyridin-2-yl)oxy]ethyl}-trimethyl-ammonium; {2-[(3-amino-6,7-dimethylpyrazolo[1 ,5-a]pyridin-2-yl)oxy]ethyl}-diisopropyl-methylammonium; [3-(3-amino-6,7-dimethyl-pyrazolo[1,5-a]pyridin-2-ylamino)-propyl]-trimethyl-ammonium; [3-(3-amino-6,7-dimethyl-pyrazolo[1,5-a]pyridin-2-yloxy)-propyl]-trimethyl-ammonium; [3-(3-amino-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1 ,5-a]pyridin-2-yloxy)-propyl]-trimethyl-ammonium; {2-[(3-amino-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1,5-a]pyridin-2-yl)amino]-ethyl}-trimethyl-ammonium; {3-[(3-amino-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1,5-a]pyridin-2-yl)amino]-propyl}- trimethyl-ammonium; 1-{2-[(3-amino-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1,5-a]pyridin-2-yl)amino]ethyl}-3-methyl-1H-imidazol-3-ium; 1-{3-[(3-amino-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1,5-a]pyridin-2-yl)amino]propyl}-3-methyl-1H-imidazol-3-ium; 1-{2-[(3-amino-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1,5-a]pyridin-2-yl)amino]ethyl}-1-methylpyrrolidinium; 1-{2-[(3-amino-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1 ,5-a]pyridin-2-yl)amino]ethyl}-1-methylpiperidinium; 4-{2-[(3-amino-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1 ,5-a]pyridin-2-yl)amino]ethyl}-4-methylmorpholin-4-ium; {2-[(3-amino-7,8-dihydro-6H-cyclopenta[e]pyrazolo[1,5-a]pyridin-2-yl)amino]ethyl}-diisopropyl-methyl-ammonium; [3-(3-amino-4-dimethylamino-pyrazolo[1,5-a]pyridin-2-ylamino)-propyl]-trimethyl-ammonium; [2-(3-amino-4-dimethylamino-pyrazolo[1,5-a]pyridin-2-ylamino)-ethyl]-trimethyl-ammonium; 4-(3-amino-4-dimethylamino-pyrazolo[1,5-a]pyridin-2-yl)-1-methyl-piperazin-1-ium; [1-(3-amino-4-dimethylamino-pyrazolo[1,5-a]pyridin-2-yl)-pyrrolidin-3-yl]-trimethyl-ammonium; 3-[2-(3-amino-4-dimethylamino-pyrazolo[1,5-a]pyridin-2-yloxy)-ethyl]-1-methyl-3H-imidazol-1-ium; [2-(3-amino-4-dimethylamino-pyrazolo[1,5-a]pyridin-2-yloxy)-ethyl]-trimethyl-ammonium; {1-[2-(3-amino-4-dimethylamino-pyrazolo[1,5-a]pyridin-2-yloxy)-ethyl]-pyrrolidin-3-yl}- |
